Great Point Partners’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-202,082
| Closed | -$6.35M | – | 33 |
|
2016
Q2 | $6.35M | Sell |
202,082
-86,513
| -30% | -$2.72M | 1.82% | 17 |
|
2016
Q1 | $7.66M | Buy |
288,595
+1,078
| +0.4% | +$28.6K | 2.75% | 11 |
|
2015
Q4 | $12.6M | Buy |
287,517
+115,348
| +67% | +$5.07M | 5.3% | 7 |
|
2015
Q3 | $7.28M | Buy |
172,169
+2,300
| +1% | +$97.2K | 2.88% | 12 |
|
2015
Q2 | $7.78M | Buy |
169,869
+29,328
| +21% | +$1.34M | 3.03% | 9 |
|
2015
Q1 | $5.54M | Buy |
+140,541
| New | +$5.54M | 2.44% | 16 |
|
2014
Q4 | – | Hold |
0
| – | – | – | 30 |
|
2014
Q3 | – | Sell |
-47,558
| Closed | -$5.76M | – | 35 |
|
2014
Q2 | $5.76M | Buy |
47,558
+5,614
| +13% | +$680K | 2.56% | 15 |
|
2014
Q1 | $5.33M | Buy |
41,944
+6,230
| +17% | +$792K | 2.78% | 12 |
|
2013
Q4 | $4.5M | Buy |
+35,714
| New | +$4.5M | 3.18% | 15 |
|